Although Helicobacter cinaedi was initially considered an opportunistic pathogen in immunocompromised patients, it was later shown to also infect immunocompetent and healthy individuals. Sporadic bacteremia due to H. cinaedi has frequently been reported; however, whether the bacterium can be translocated after passage through the intestinal mucosa remains unclear. In the present study, a preclinical small animal model that faithfully reproduces H. cinaedi infection in humans was developed. Balb/c male mice were orally inoculated with a single dose of 6.8 Â 10 7 CFU of a human clinical H. cinaedi strain. The organism persistently colonized the intestinal tract of the mice, particularly the cecum and colon, for at least 56 days, and the bacteria were excreted in the feces. Although inoculated bacteria were recovered from the spleen, liver, kidney, lung, bladder and mesenteric lymph nodes during the first 2 weeks of bacteremia, the organism was not isolated from these organs after 4 weeks, suggesting that complement-and antibody-mediated serum sensitivity account for the relatively low frequency of systemic infection. However, H. cinaedi was isolated from the biceps femoris, triceps branchii, latissimus dorsi, and trapezius muscles beyond 2 weeks after infection and after production of specific anti-H. cinaedi IgM and IgG antibodies. The present findings suggest that experimental infection of Balb/c mice with H. cinaedi may be a useful model for further studies of H. cinaedi pathogenesis, prophylaxis or therapeutic interventions in vivo.
Helicobacter cinaedi, first recognized as a Campylobacterlike organism, is a gram-negative, spiral-shaped, motile, microaerobic bacterium that is categorized as an enterohepatic Helicobacter species (1) . H. cinaedi was initially considered an opportunistic pathogen in immunocompromised patients (2-4) because it was first isolated as a rectal and intestinal pathogen from homosexual men infected with HIV (1). H. cinaedi bacteremia was later identified in patients were undergoing chemotherapy with immunosuppressant drugs (5, 6) . Furthermore, H. cinaedi has also been isolated from blood and feces of an apparently non-immunocompromised child and adult (7, 8) , indicating that the infection can also occur in immunocompetent, healthy individuals (9, 10) . H. cinaedi therefore should not be regarded as simply an opportunistic pathogen.
There has recently been an increase in the number of reports of H. cinaedi isolation from blood cultures in Japan ((4-6), (10) (11) (12) ). The main clinical symptoms associated with H. cinaedi bacteremia have been fever, enteritis and skin disorders, including cellulitis (5, 6, 10) . The first patient with H. cinaedi bacteremia reported in Japan was HIV-negative, but had been receiving immunosuppressive therapy after renal transplantation (5). Kitamura et al. (10) reported a cluster of H. cinaedi bacteremia and cellulitis that occurred during the same period in the same hospital. None of the affected patients had any underlying immunocompromising conditions, nor had they been receiving immunosuppressive agents. Although H. cinaedi infection has a good prognosis in most cases, the infection tends to recur (3, 6, 10, 13, 14) . Although sporadic cases of H. cinaedi bacteremia appear to occur fairly frequently, whether the bacterium can be translocated after passage through the intestinal mucosa remains unknown.
The clinical outcomes of H. cinaedi infection vary and its virulence strategies and pathogenesis as well as host responses remain unclear. This knowledge gap has been partly attributable to the lack of a small-animal model that can faithfully reproduce H. cinaedi infection in humans and would allow testing of antimicrobial treatments and/or anticancer chemotherapies. The only small-animal models of H. cinaedi pathogenesis employ genetically-deficient mice, such as those lacking IL-10 or recombinase activating genes, or with spontaneous hyperlipidemia (15) (16) (17) . However, given that H. cinaedi has been isolated from blood cultures in healthy humans (5, 8, 18) , the organism may have the potential to invade and/or penetrate the normal intestinal barrier.
In the present study, we developed an improved mouse model for study of H. cinaedi infection and gained substantial new insights into the pathogenic mechanisms of this organism.
MATERIALS AND METHODS

Bacterial strain and growth conditions
Most H. cinaedi strains show swarming and do not form single colonies on agar plates, preventing determination of the number of bacterial cells. Thus, a human clinical strain, H. cinaedi N73 strain, that forms single colonies on agar plates was used in this study. The N73 strain had been isolated from human blood cultures during routine diagnosis of bacteremia in a patient admitted to the University of Miyazaki Hospital (19) . It was grown on Brucella agar (Becton Dickinson, BD Biosciences, Tokyo, Japan) containing 5% defibrinated horse blood (Nippon Biotest Laboratories, Tokyo, Japan) at 37°C for 2-3 days under microaerobic conditions (75% N 2 , 10% CO 2 , 5% H 2 and 10% O 2 ).
Mice
Six-week-old Balb/c male mice kept under specific pathogen-free conditions (Charles River Laboratories International, Kanagawa, Japan) were used in this study. The mice were fed a standard rodent diet (Charles River Laboratories International), provided water ad libitum, housed in microisolator cages and isolated from specific pathogens, including all known Helicobacter species.
Experimental design and infection
Based on preliminary experiments, a gastric feeding needle designed for mice (Thermo Fisher Scientific, Yokohama, Japan) was used to orally inoculate them with a single dose of 6.8 Â 10 7 viable H. cinaedi cells in 0.1 mL of 0.1 mM PBS (pH 7.2). As a negative control, mice were inoculated with the same volume of PBS. On Days 3, 7, 10, 14, 21, 28, 35, 42 and 56 after inoculation, H. cinaedi cells in feces were counted by dilution plating culture using Skirrow (OXOID, Hampshire, UK) selective agar plates (20) . There were initially 13 mice in the control and infected groups. Thereafter, their numbers progressively decreased because three mice from each group were killed for necropsy on Days 7, 14, and 28. At necropsy, blood, bile, spleen, liver, lung, heart, kidney, mesenteric lymph nodes, ileum, colon, cecum, bladder, biceps femoris, triceps branchii, latissimus dorsi, and trapezius muscles were collected aseptically for recovery of H. cinaedi. All animal experiments and the study protocol were conducted with the approval of the committee for animal experimentation of the University of Miyazaki (Acceptance number 2012-022-2).
Isolation of H. cinaedi
For cultivation of H. cinaedi, Skirrow agar plates were inoculated with blood obtained by cardiac puncture, bile, fresh feces and aseptically collected tissue samples that had been homogenized in 500 mL of PBS. The plates were incubated at 37°C for 3-10 days under microaerobic conditions as described above. Suspected colonies were subjected to Gram staining, after which those containing slightly spiral-shaped, slender bacteria were subcultured onto new Skirrow agar plates. DNA was extracted from the isolated bacteria by alkaline and heat treatment (21) and confirmed to be that of H. cinaedi by PCR analysis using the specific primers CDT_F (5'-CTCGTCCGGA-TATGGTG-3') and CDT_R (5'-AGAGTTCCCTAT-CACTGC-3'), which were designed on the basis of the cytolethal distending toxin gene sequence in H. cinaedi (Accession number AB275331). The specificity of the PCR for detecting H. cinaedi was confirmed using H. cinaedi type strain CCUG18818
T and other Helicobacter species, such as H. mustelae ATCC 43772, H. pylori LMG 19449, H. fennelliae ATCC 35684, H. canis NCTC 12379, H. hepaticus LMG 16316 and H. bilis ATCC 51630. PCR was performed in a final reaction volume of 20 mL. Each reaction contained 20 pM of each primer (forward and reverse), 200 mM deoxynucleoside triphosphate, 0.5 U of Taq DNA polymerase (Qiagen, Tokyo, Japan), 1 Â PCR buffer, and 2 mL of DNA template. The thermal cycling conditions included 30 cycles of denaturation at 94°C for 30 s, annealing at 58°C for 30 s, and extension at 72°C for 1 min, followed by a final extension at 72°C for 10 min. Specific amplification of each target gene was confirmed by 2% agarose gel electrophoresis.
Preparation of soluble antigens for ELISA
Antigens for ELISA assays were prepared by an acid extraction method (22) . Briefly, the N73 strain grown on Brucella agar containing 5% defibrinated horse blood was harvested in PBS and centrifuged at 7000 g at 4°C for 15 min. The pellet was washed three times with PBS, after which 3 mL of sterile distilled water was added to make a bacterial suspension in a 50-mL conical flask to which 7 mL of 100 mM glycine-hydrogen chloride buffer (pH 2.2) containing 150 mM sodium chloride was added. The flask was placed on a magnetic stirrer and the mixture stirred for 20 min at room temperature. The extracted fraction was separated by centrifugation at 13000 g at 4°C for 10 min, then neutralized by addition of tris (hydroxymethyl) aminomethane (Sigma-Aldrich Japan, Tokyo, Japan), and the protein concentration determined using a protein assay kit (Japan Bio-Rad, Tokyo, Japan) in accordance with the manufacturer's instructions. The sample was then stored at À20°C until use for ELISA.
ELISA assay
The ELISA assays were performed by the method of Moe et al. (22) with some modifications. The assay was performed in triplicate. Briefly, 100 mL of bacterial antigen (20 mg/mL) was added to each well of a disposable polyvinyl chloride 96-well microplate (BD Falcon, Franklin Lakes, NJ, USA) to coat the wells of the microplate with the antigen, after which the microplate was allowed to stand at 37°C for 1 hr. The unbound antigens were then removed using a 96-well washer machine (Japan Bio-Rad), and each well of the microplate blocked by adding 200 mL of 2% BSA (Sigma-Aldrich) in 10 mM PBS (pH 7.2) for 1 hr at 37°C. The plates were then washed three times with PBST (Nakarai Tesque, Kyoto, Japan). Sera of mice, diluted 1:100 in 1% BSA in PBST, were added to the ELISA plate wells in triplicate and incubated at 37°C for 1 hr. The plates were washed again, after which goat anti-mouse IgM m-chain (Southern Biotech, Birmingham, AL, USA) diluted 1:10,000, anti-mouse IgG g-chain (Alpha Diagnostic International, San Antonio, TX, USA) diluted 1:1000 or anti-mouse IgA a-chain (Bethyl Laboratories, Montgomery, AL, USA) diluted 1:50 000 in PBST with 1% BSA was added to detect each immunoglobulin class, these being incubated at 37°C for 1 hr. After the plates had been washed three times, 75 mL of substrate solution containing 20 mM citric acid monohydrate, 20 mM sodium hydrogen phosphate, 3 mM O-phenylenediamine and 0.0012% H 2 O 2 in distilled water, were added to each well and incubated at 37°C for 20 min. The reaction was stopped by adding 2.5 M sulfuric acid, and the OD 492 measured with a multi-well ELISA plate reader (Benchmark Plus; Bio-Rad). The cut-off value was calculated using the formula (mean value þ 3 Â standard) relative to the value for sera from control mice.
Susceptibility of H. cinaedi to mouse serum H. cinaedi N73 strain was grown on Brucella agar containing 5% defibrinated horse blood at 37°C for 2 days under microaerobic conditions as described above and then suspended in Brucella broth containing 10% heat-inactivated FBS (Nichirei Biosciences, Tokyo, Japan) at approximately 10 8 CFU/mL. Serial 10-fold dilutions of bacterial cell suspension were made in Brucella broth containing 20% FBS. Two sources of sera were used; namely Pool 1, consisting of sera from four control mice necropsied 8 weeks after inoculation, and Pool 2, consisting of sera from four H. cinaediinfected mice at 8 weeks after infection. These sera were heated at 56°C for 30 min before use as controls. Equal volumes (50 mL) of either fresh or heatinactivated pooled sera in Brucella broth and each suspension of H. cinaedi bacteria were mixed in a 96-well microplate (Asahi Glass, Tokyo, Japan) and incubated at 37°C for 60 min under microaerobic conditions as described above. The final concentration of each serum in the suspension was 10%. After incubation, 50 mL of the suspension from each mixture was diluted and inoculated onto Brucella agar plates containing 5% defibrinated horse blood. The plates were then incubated at 37°C for 3 days under microaerobic conditions for counting of viable cells. The bactericidal effect of serum was expressed by subtracting log 10 viable cells (CFU/mL) treated with fresh serum from log 10 viable cells (CFU/mL) treated with heat-inactivated serum. A value of >1.0 was considered to indicate serum susceptibility (23, 24) . The assay was performed in triplicate.
Statistical analysis
Data are presented as the mean AE SEM. Statistical analysis was performed by Student's t-test. A value of P < 0.05 was considered to denote significance.
RESULTS
Kinetics of fecal excretion of H. cinaedi
After inoculation, fresh fecal drops from mice were collected daily for 56 days after oral administration and serial dilution cultures performed to count the administered H. cinaedi (Fig. 1) . After inoculation with an oral dose of 6.8 Â 10 7 cells of H. cinaedi, the infected mice excreted H. cinaedi persistently throughout the assessed 56 days. The administered H. cinaedi were recovered at 10 4 CFU/g of feces (wet weight) 3 days post infection. Thereafter the number of recovered cells increased gradually, reaching around 10 8 CFU/g in all mice examined after 10 days of infection. In contrast, H. cinaedi was not isolated from any fecal sample from control mice.
Recovery of infected H. cinaedi from various parts of the body
To examine the possibility of translocation across the intestinal epithelium and tropism in the body, various extraintestinal tissues, including blood, of the orally infected mice were cultured to recover the administered H. cinaedi (Table 1 ). H. cinaedi was recovered from a wide range of tissues including spleen, liver, kidney, lung, bladder and mesenteric lymph node until two weeks after inoculation. However, the organism was not isolated from major organs after 4 weeks even though it was isolated from blood in one mouse at 4 weeks. H. cinaedi was isolated from biceps femoris, triceps branchii, latissimus dorsi and trapezius muscles after 2 weeks post-infection. In contrast, H. cinaedi was isolated from colon and cecum contents of almost all infected mice during the experimental period, showing that H. cinaedi can colonize the intestinal tracts in Balb/c mice. Conversely, H. cinaedi was not isolated from blood, bile or any tissue examined in the control mice.
Antibody responses to inoculated H. cinaedi
To investigate whether an immunological response is elicited by oral administration of H. cinaedi, sera taken from infected and control mice at necropsy 8 weeks after inoculation were assayed for IgM, IgG and IgA antibodies against antigen extracted from the bacterium by acid treatment (Fig. 2) . The titer of IgM antibody increased quickly in all infected mice but not in the control mice (P < 0.01) beyond 2 weeks after infection, the ELISA titer being maintained until 8 weeks. In Fig. 1 . Numbers of H. cinaedi in feces of infected mice. Bacterial counts were determined by culture on Days 0, 3, 7, 10, 14, 21, 28, 35, 41 and 56 after inoculation. There were initially 13 infected mice, after which the numbers decreased because three mice were killed for necropsy on Days 7, 14, and 28. denominator is the total number of mice sampled.
contrast, titers of both IgG and IgA antibodies against H. cinaedi were significantly higher at 8 weeks after inoculation than those of uninfected control mice at the same time point (P < 0.01 and P < 0.05, respectively).
Killing of H. cinaedi by infected or uninfected mouse serum
To determine whether H. cinaedi is resistant to antibodymediated and/or complement-dependent bactericidal activity in mouse serum, H. cinaedi strain N73 was examined using pooled sera containing anti-H. cinaedi antibody from infected mice at 8 weeks after infection or sera from control mice without H. cinaedi antibody. Bactericidal activity resulting from serum treatment was observed regardless of the presence of antibody against H. cinaedi. The number of viable H. cinaedi cells was reduced to 1.32 log (95% killing) by treatment with serum from control mice, and to 1.58 log (97% killing) by serum containing H. cinaedi antibody from infected mice; thus, there was no significant difference between the bactericidal activities of the two sera (Table 2) .
DISCUSSION
In the last decade, the number of case reports of H. cinaedi infection resulting in bacteremia has gradually increased in Japan. The introduction of blood culture systems in clinical microbiological laboratories in many hospitals may have resulted in an increased frequency of diagnosis of bacteremia caused by H. cinaedi among hospitalized patients (25) . Furthermore, as has already been reported by our team, rapid identification of H. cinaedi using matrix-assisted laser desorption ionization-time of flight mass spectrometry (30) has made it easier to identify elusive organisms than it was with classical methods. Isolation of H. cinaedi from the intestinal tracts of healthy individuals (13) suggests that H. cinaedi exists as part of the intestinal flora or as a source of subclinical infection. Furthermore, patients with bacteremia were often being treated with anticancer medication or had comorbidities such as diabetes (6, 12 ). These findings suggest that H. cinaedi has the potential to opportunistically translocate from the intestinal tract to extraintestinal tissues. It was recently demonstrated by our team that a human H. cinaedi strain and H. cinaedi strains isolated from a dog and a hamster exhibited potential for adhesion to and invasion into human epithelial cells in vitro, suggesting that virulence factors playing a role in the pathogenesis of H. cinaedi are potentially involved in adherence, invasion and translocation across the mucosal epithelial barrier (26) . Rodents may be an appropriate candidate for development of an animal model of intestinal colonization and spontaneous extraintestinal infection because H. cinaedi has frequently been isolated from hamsters (27, 28) . Although Flores et al. have developed an experimental model of H. cinaedi infection in the pig-tailed macaque (Macaca nemestrina) (29) to assess the pathogenicity of the organism, it is difficult to use primates for experimental purposes. We therefore explored the possibility of using normal mice as a model of H. cinaedi infection.
The kinetics of intestinal colonization following experimental inoculation of Balb/c mice with H. cinaedi showed that the organism can persistently colonize the intestinal tract, particularly the cecum and colon, for at least 56 days, and that the bacteria are excreted in the feces. In this study, approximately 10 7 CFU/g H. cinaedi were counted in the colon and >10
8 CFU/g in the cecum at 8 weeks after inoculation (data not shown), indicating that adult Balb/c mice can easily be colonized by H. cinaedi after a single inoculation with 10 8 CFU. However, previous studies have used higher doses (three administrations of 10 9 CFU) to achieve colonization (15) (16) (17) . It has been shown that some factors may affect the results of colonization; these include the strain of mouse used, its sex and differences in intestinal flora resulting from differences in rearing environment or bacterial infectivity (15) (16) (17) . Given that pretreatment with antibiotics is not necessary for colonization, this animal model would be advantageous for further studies of prophylactic or therapeutic interventions involving H. cinaedi in vivo.
After inoculation, bacteria were recovered from the spleen, liver, kidney, lung, bladder, and mesenteric lymph nodes for the first two weeks after inoculation, during the period of early bacteremia. Although H. cinaedi was isolated from blood of only one mouse 4 weeks after infection, its otherwise rapid disappearance could have been due to clearance by a complement-mediated bactericidal effect and/or phagocytosis. Using nested PCR, Oyama et al. observed that mice infected intraperitoneally with H. cinaedi passed the bacterium into urine and stools rather than into blood, suggesting that H. cinaedi cells are rapidly cleared from the blood stream and escape from the host immune system (13) .
Measurement of antibody titers to specific H. cinaedi antigen after oral administration revealed an early increase in IgM antibody; however, neither IgG nor IgA antibody was detected until at least 4 weeks after inoculation. IgM antibody titers persisted from 2 to 8 weeks post infection, which is of note because the IgM antibody has opsonic activity (30) and is therefore able to clear the organisms from both tissues and the blood stream.
Interestingly, H. cinaedi was isolated from biceps femoris, triceps branchii, latissimus dorsi and trapezius muscles 2 weeks after infection, even after production of specific IgM and IgG antibodies against the bacterium, suggesting that H. cinaedi may escape the host immune system by establishing a niche in muscle. Similarly, H. cinaedi has reportedly been isolated from not only blood but also soft tissue and joints in humans (31) . Findings of a study by Khan et al. involving experimental infection of mice with spontaneous hyperlipidemia have suggested that H. cinaedi has specific vascular tropism (16) . Although there are few reports of experimental infections using normal mouse models, Shen et al. reported isolating H. cinaedi from feces by culture and detecting this organism in the liver by PCR 12 weeks after experimental inoculation using normal C57BL/6 mice as a control (15) . In the present study, persistent colonization in the intestinal tracts and translocation of the bacteria was confirmed. Further investigations are required to examine recurrent infection over longer observation periods. Although all tissues from which H. cinaedi was isolated were examined histopathologically, no significant pathological changes, including inflammation, were observed. Additionally, when the location of H. cinaedi in muscles of infected mice was examined using immunohistochemical staining, its antigens were not detected, possibly because so few bacteria had been isolated from muscle (10 2 to 10 3 CFU/g) relative to colon (10 7 to 10 8 CFU/g) (data not shown). This is the first report of H. cinaedi being isolated from muscle after experimental infection in mice; thus, further investigations are required to clarify the tropism of H. cinaedi in extraintestinal tissues.
Based on findings in previous case reports, H. cinaedi is likely able to invade the systemic circulation from mucosal sites. That bacteremia associated with H. cinaedi infection is usually transient and self-limiting or treatable with antibiotics (13, 18) suggests that his organism is sensitive to the serum bactericidal activity present in healthy individuals and infected patients with normal immune function, whereas this may not be the case for immunocompromised hosts. In the present study, complement-and antibody-mediated serum sensitivity were observed, implying that systemic infection attributable to bacteremia may be transient. The ability of other gram-negative bacteria to invade the systemic circulation from the intestinal mucosa is associated with resistance to the bactericidal activity present in normal human serum (32). Explaining recurrent infection by H. cinaedi would require comparing the bactericidal effect of serum of normal individuals and patients with recurrent infections.
In conclusion, the present study revealed that experimental infection of Balb/c mice with H. cinaedi results in intestinal colonization followed by bacteremia and extraintestinal infection, suggesting that this model may be useful for further examinations of the pathogenesis of H. cinaedi in vivo and development of prophylactic or therapeutic interventions.
